Long COVID isn’t just a personal health crisis anymore. It’s quietly reshaping the UK labour market, straining the NHS, and forcing employers to rethink what “workplace wellness” actually means. Behind the headlines about post-pandemic recovery, millions of working-age adults across the UK are still battling fatigue, brain fog, and a body that won’t switch off its alarm system — and the economic ripple effects are becoming impossible to ignore.

This piece looks at Long COVID through a less-discussed lens: what’s actually happening in the nervous system, why that matters for recovery timelines, and how emerging therapies such as the Safe and Sound Protocol are being used to help people get their lives — and their careers — back on track.

A Workforce Problem Hiding in Plain Sight

According to UK government data, around two million people in England and Scotland were living with self-reported Long COVID symptoms as of recent measurement, representing roughly 3.3% of the population. The condition is officially defined as symptoms lasting 12 weeks or more after a COVID-19 infection that can’t be explained by another diagnosis.

What’s less widely reported is the economic story underneath those numbers. Studies tracking labour market outcomes have found that working-age people with self-reported Long COVID are economically inactive at meaningfully higher rates than those without it, and that gap has widened year on year since the pandemic. Occupational health bodies in the UK have gone as far as urging employers to review absence management and flexible working policies specifically because of Long COVID’s impact on staff.

For HR teams, business owners, and policymakers, this isn’t an abstract public health statistic. It’s sick leave that doesn’t resolve on a normal timeline, performance dips that look like burnout but aren’t, and skilled employees quietly dropping out of the workforce because nobody addressed the root cause of their symptoms.

The Bigger Picture: A Cost That’s Still Being Counted

The financial impact of Long COVID on the UK economy is difficult to pin down precisely, but the indicators available all point in the same direction. Healthcare utilisation studies consistently show that people with Long COVID make significantly greater use of NHS services than those without it, adding pressure to a system already managing long waiting lists. Separately, surveys of NHS staff themselves have found that a notable proportion report ongoing symptoms limiting their ability to work — meaning the condition is straining the very workforce tasked with treating it.

There’s also a less visible cost: presenteeism. Many employees with Long COVID continue working through symptoms rather than taking extended leave, often because sick pay doesn’t stretch far enough or because they fear being seen as unreliable. The result is reduced output, more errors, and a slower, quieter form of productivity loss that rarely shows up in absence statistics but is very real to managers watching previously high-performing staff struggle to keep pace.

None of this is a reason for panic. It’s a reason to take the underlying biology seriously rather than treating Long COVID as something people should simply “push through” or wait out.

Why Standard Treatment Often Falls Short

Part of the problem is that Long COVID doesn’t behave like a typical illness with a single, treatable cause. COVID-19 affects far more than the lungs — it can disrupt the heart, kidneys, gut, and nervous system simultaneously. In a significant number of cases, the virus appears to trigger inflammation around the vagus nerve and central nervous system, reactivate other dormant viruses in the body, or provoke an immune response that mistakenly targets healthy tissue.

The result is a nervous system that gets stuck in a defensive state long after the infection itself has cleared. This is the piece that often gets missed in standard treatment pathways, which tend to focus on managing individual symptoms rather than addressing the underlying dysregulation driving them.

Two conditions illustrate this clearly:

  • Dysautonomia — a breakdown in the autonomic nervous system’s ability to regulate heart rate, blood pressure, digestion, and temperature, leading to dizziness, rapid heartbeat, and persistent fatigue.
  • Postural Orthostatic Tachycardia Syndrome (POTS) — a condition where the fight-or-flight response stays activated even at rest, causing the heart rate to spike simply from standing up. People with Long COVID are considerably more likely to develop POTS than the general population.

Neither condition shows up clearly on a standard blood panel, which is part of why so many Long COVID sufferers describe feeling dismissed or stuck in a diagnostic loop.

The Nervous System Angle: What the Safe and Sound Protocol Offers

This is where therapies grounded in polyvagal theory — the science of how the vagus nerve governs our sense of safety and physiological state — are starting to gain traction among UK clinicians and trauma specialists. One of the most established is the Safe and Sound Protocol (SSP), a non-invasive, listening-based intervention that uses specially filtered music delivered through headphones to stimulate the vagus nerve.

Unlike medication, SSP doesn’t target a single symptom. It works by sending the nervous system repeated signals of safety, with the aim of shifting the body out of chronic fight-or-flight or shutdown states and into a more regulated baseline — the physiological condition associated with calm focus, better digestion, and steadier heart rate variability (HRV).

SSP is generally used to:

  • Reduce baseline stress and anxiety
  • Improve heart rate variability, a recognised marker of nervous system resilience
  • Support clearer thinking and easier social engagement
  • Help the body regulate involuntary functions more consistently

For employees and self-employed professionals trying to return to a normal workload, this kind of intervention can address something conventional rest and time off often can’t: a nervous system that’s forgotten how to switch off its emergency response.

What the Evidence Actually Says

It’s important to be straightforward here: research specifically studying SSP for Long COVID is still developing, and no reputable practitioner presents it as a guaranteed fix. What the current evidence and clinical experience point to is more modest but still meaningful — SSP appears to support better-regulated nervous system function in many people, and clinicians working in trauma and autonomic dysfunction increasingly use it as one component of a broader recovery plan, alongside conventional medical care, pacing strategies, and lifestyle adjustments.

That distinction matters. Long COVID recovery, much like recovery from any complex chronic condition, rarely comes down to a single intervention. It comes from stacking the right combination of medical investigation, nervous system support, and sustainable pacing.

A Practical Recovery Framework

For UK — whether navigating this personally or supporting a team member through it — a sensible recovery approach typically includes:

  1. Medical investigation first. A GP can rule out other causes and check ferritin, vitamin D, electrolytes, B12, and thyroid function, all of which can mimic or worsen Long COVID symptoms.
  2. Nervous system-focused therapy, such as the Safe and Sound Protocol, delivered by a registered, trauma-informed practitioner.
  3. Flexible pacing, often guided by the “spoon theory” framework used widely in the chronic illness community — recognising that energy is a finite daily resource, not something to push through.
  4. Workplace flexibility, including shorter hours, remote options, or adjusted deadlines during active recovery phases.
  5. Stress-reduction practices such as mindfulness, breathwork, gentle movement, and journalling to help regulate the emotional load that chronic illness carries.

Employers who build this kind of flexibility into their return-to-work planning tend to retain experienced staff rather than losing them to long-term inactivity — a far better outcome than the alternative for both the individual and the business.

Choosing the Right Practitioner

Not all nervous system therapy is delivered the same way, and pacing matters enormously for people with Long COVID, whose systems are often highly sensitive to overstimulation. When looking for an SSP provider or similar nervous system specialist in the UK, it’s worth checking for:

  • Relevant clinical registration, such as BACP accreditation for psychotherapists, alongside specific SSP or polyvagal-informed training.
  • Experience with chronic illness or trauma, not just general wellness coaching, since Long COVID symptoms can closely mirror trauma responses.
  • Flexibility in session length and pacing, given that many Long COVID patients can’t tolerate standard-length sessions without triggering a symptom flare.
  • A willingness to coordinate with other care, rather than positioning SSP as a standalone replacement for medical treatment.

Frequently Asked Questions

What exactly is Long COVID?

Long COVID describes symptoms that persist for 12 weeks or longer after a COVID-19 infection and cannot be explained by another condition. It commonly includes fatigue, breathlessness, brain fog, dizziness, and heart rate irregularities.

Why is Long COVID such a workforce issue in the UK?

Data shows working-age adults with Long COVID become economically inactive at notably higher rates than the rest of the population, and NHS waiting times for specialist Long COVID services vary widely depending on region, leaving many people managing recovery largely on their own.

What is the Safe and Sound Protocol?

It’s a listening-based therapy that uses specially filtered music to stimulate the vagus nerve, with the goal of helping the nervous system shift out of chronic stress states and into better regulation.

Can the Safe and Sound Protocol cure Long COVID?

No. It isn’t presented as a cure. It’s used as a complementary therapy that may support nervous system regulation as part of a wider, medically guided recovery plan.

Is this kind of therapy accessible across the UK, including remotely?

Yes. SSP is commonly delivered online, which makes it accessible to people across the UK regardless of location — particularly useful for those whose fatigue makes regular travel to appointments difficult.

Who should consider trying SSP for Long COVID symptoms?

People whose Long COVID symptoms involve dysautonomia, POTS-type symptoms, anxiety, or a nervous system that won’t settle are often the best candidates, ideally after ruling out other medical causes with a GP.

Should employers be doing anything differently for staff with Long COVID?

Occupational health guidance in the UK increasingly recommends flexible working arrangements, phased returns, and absence policies that account for fluctuating, non-linear recovery rather than fixed timelines. Treating Long COVID like a standard short-term illness often sets both the employee and the business up to struggle.

How is Long COVID different from general post-viral fatigue?

Long COVID shares features with other post-viral syndromes, but its scale and the breadth of systems it affects — cardiovascular, neurological, and immune — set it apart. Multiple interrelated subtypes appear to exist, which is part of why a one-size-fits-all treatment approach hasn’t worked well for most patients.

Conclusion

Long COVID has exposed a gap in how complex, multi-system illness gets treated — and addressed at scale across workplaces and healthcare systems alike. Standard rest-and-wait approaches aren’t cutting it for everyone, particularly when the nervous system itself is driving the symptom picture. Therapies like the Safe and Sound Protocol won’t be right for every case, but for the growing number of people whose Long COVID is tangled up with dysautonomia or a nervous system stuck on high alert, it represents a research-informed, low-risk option worth discussing with a qualified practitioner.

This article is for general informational purposes and does not constitute medical advice. Anyone experiencing persistent symptoms after COVID-19 should consult their GP or an NHS Long COVID service.

References

  1. House of Commons Library. Long Covid (Research Briefing CBP-9112). https://commonslibrary.parliament.uk/research-briefings/cbp-9112/
  2. Office for National Statistics. Self-reported long COVID and labour market outcomes, UK. https://www.ons.gov.uk
  3. British Journal of General Practice. Postural tachycardia syndrome and long COVID: an update. https://bjgp.org/content/72/714/8
  4. PoTS UK. PoTS and Long Covid. https://www.potsuk.org/pots-and-long-covid/
  5. Society of Occupational Medicine. Guidance on long COVID and the workforce, referenced in House of Commons Library briefing CBP-9112.

JS Bin